HRMY FY 2020 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$160M+2564.6% YoY

Gross Profit

$132M82.6% margin

Operating Income

$17M10.6% margin

Net Income

-$37M-23.1% margin

EPS (Diluted)

$-1.10

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$5M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$427M

Total Liabilities

$330M

Stockholders' Equity

$97M

Cash & Equivalents

$229M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$160M	$6M	+2564.6%
Gross Profit	$132M	$4M	+2887.9%
Operating Income	$17M	-$146M	+111.6%
Net Income	-$37M	-$152M	+75.7%